Invasive meningococcal disease (IMD) whilst rare, is a devastating bacterial infection which continues to remain a public health burden.
This emodule aims to educate on the burden and impact of IMD as well as exploring the epidemiology in Australia and the different meningococcal vaccines available. Additionally, insights into patient communication strategies are provided to help with discussing the importance of vaccination with parents/carers and patients.
For RACGP Members:
This education is a CPD Activity under the RACGP CPD Program.
Activity ID: 556546
Learning Objectives:
1. Describe the burden and impact of invasive meningococcal disease
2. Discuss the who, what and why of meningococcal vaccines
3. Discuss the importance of real-world evidence in analysing the efficacy of vaccines.
4. Explore appropriate patient communication techniques when making recommendations about meningococcal immunisation
This educational activity was developed by Lateral Connections at the request of and with funding from GSK.
NX-AU-MNU-OGM-230003, Date of Approval: July 2023
This CPD Activity is part of the ABCWY of Meningococcal Vaccines Mini-Series.
Earn up to 9.5 hours of CPD by completing both activities.
LC-Learn is only available to registered Australian healthcare professionals.
Registration is free and easy! Register today by clicking the button below.